β-Naphthyl-di-chloroethylamine in the Treatment of Malignant Diseases, Particularly Hodgkin's Disease
- 24 April 2009
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 149 (5), 361-368
- https://doi.org/10.1111/j.0954-6820.1954.tb11446.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Carcinogenic Effect of SulfonamidesActa Radiologica, 1952
- A TRIAL OF $beta;-NAPHTHYLDI-2-CHLOROETHYLAMINE (R48) IN LEUKqMIA, HODGKIN'S DISEASE, AND ALLIED DISEASESThe Lancet, 1950
- On the Use of Nitrogen Mustard as a Therapeutic AgentxActa Medica Scandinavica, 1949
- Effects upon tumours of Various HaloalkylarylaminesNature, 1948
- The Nitrogen Mustards: Clinical UseRadiology, 1948
- NITROGEN MUSTARDS IN THE TREATMENT OF NEOPLASTIC DISEASEJAMA, 1946